[go: up one dir, main page]

CL2020003368A1 - Composicion y metodo para tratar el dolor - Google Patents

Composicion y metodo para tratar el dolor

Info

Publication number
CL2020003368A1
CL2020003368A1 CL2020003368A CL2020003368A CL2020003368A1 CL 2020003368 A1 CL2020003368 A1 CL 2020003368A1 CL 2020003368 A CL2020003368 A CL 2020003368A CL 2020003368 A CL2020003368 A CL 2020003368A CL 2020003368 A1 CL2020003368 A1 CL 2020003368A1
Authority
CL
Chile
Prior art keywords
composition
treating pain
pain
cannabidiol
tetrahydrocannabinol
Prior art date
Application number
CL2020003368A
Other languages
English (en)
Inventor
Harry Karelis
Original Assignee
Zelira Therapeutics Operations Pty Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Zelira Therapeutics Operations Pty Ltd filed Critical Zelira Therapeutics Operations Pty Ltd
Publication of CL2020003368A1 publication Critical patent/CL2020003368A1/es

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/658—Medicinal preparations containing organic active ingredients o-phenolic cannabinoids, e.g. cannabidiol, cannabigerolic acid, cannabichromene or tetrahydrocannabinol
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/335—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
    • A61K31/35—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having six-membered rings with one oxygen as the only ring hetero atom
    • A61K31/352—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having six-membered rings with one oxygen as the only ring hetero atom condensed with carbocyclic rings, e.g. methantheline 
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/01—Hydrocarbons
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/01—Hydrocarbons
    • A61K31/015—Hydrocarbons carbocyclic
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/045—Hydroxy compounds, e.g. alcohols; Salts thereof, e.g. alcoholates
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/045—Hydroxy compounds, e.g. alcohols; Salts thereof, e.g. alcoholates
    • A61K31/05—Phenols
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18—Magnoliophyta (angiosperms)
    • A61K36/185—Magnoliopsida (dicotyledons)
    • A61K36/348—Cannabaceae
    • A61K36/3482—Cannabis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/04—Centrally acting analgesics, e.g. opioids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K2236/00—Isolation or extraction methods of medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicine
    • A61K2236/30—Extraction of the material
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K2236/00—Isolation or extraction methods of medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicine
    • A61K2236/30—Extraction of the material
    • A61K2236/33—Extraction of the material involving extraction with hydrophilic solvents, e.g. lower alcohols, esters or ketones
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K2300/00—Mixtures or combinations of active ingredients, wherein at least one active ingredient is fully defined in groups A61K31/00 - A61K41/00

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Epidemiology (AREA)
  • Natural Medicines & Medicinal Plants (AREA)
  • Engineering & Computer Science (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Pain & Pain Management (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Medical Informatics (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Neurosurgery (AREA)
  • Microbiology (AREA)
  • Botany (AREA)
  • Biotechnology (AREA)
  • Alternative & Traditional Medicine (AREA)
  • Mycology (AREA)
  • Biomedical Technology (AREA)
  • Neurology (AREA)
  • Rheumatology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Pyrane Compounds (AREA)
  • Medicines Containing Plant Substances (AREA)

Abstract

La invención se refiere a composiciones farmacéuticas que comprenden ?9- tetrahidrocannabinol (THC), cannabidiol (CBD) y una fracción de terpeno obtenida por extracción de una planta de Cannabis, y su uso en el tratamiento del dolor.
CL2020003368A 2018-07-03 2020-12-23 Composicion y metodo para tratar el dolor CL2020003368A1 (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
AU2018100924A AU2018100924A4 (en) 2018-07-03 2018-07-03 Composition and method for treating pain

Publications (1)

Publication Number Publication Date
CL2020003368A1 true CL2020003368A1 (es) 2021-08-13

Family

ID=63079646

Family Applications (1)

Application Number Title Priority Date Filing Date
CL2020003368A CL2020003368A1 (es) 2018-07-03 2020-12-23 Composicion y metodo para tratar el dolor

Country Status (13)

Country Link
US (1) US20220218650A1 (es)
EP (1) EP3817733A4 (es)
KR (1) KR20210071939A (es)
AU (2) AU2018100924A4 (es)
BR (1) BR112020027080A2 (es)
CA (1) CA3104742A1 (es)
CL (1) CL2020003368A1 (es)
CO (1) CO2021001061A2 (es)
IL (1) IL279748A (es)
MX (1) MX2021000020A (es)
PE (1) PE20211650A1 (es)
SG (1) SG11202013239RA (es)
WO (1) WO2020006599A1 (es)

Families Citing this family (17)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
BR112019001852A2 (pt) 2016-08-03 2019-05-07 Zelda Therapeutics Operations Pty Ltd composição de cannabis
KR20200104278A (ko) 2017-06-19 2020-09-03 젤다 테라퓨틱스 오퍼레이션즈 피티와이 엘티디 수면 장애 조성물 및 그의 치료
US20210393572A1 (en) * 2018-09-28 2021-12-23 Visceral Therapeutics Inc. Pharmaceutically active cannabis-based compositions and methods of use for treating gastrointestinal conditions
AU2020243439A1 (en) * 2019-03-21 2021-10-28 ZYUS Life Sciences US Ltd. Cannabinoid and application supported opioid tapering
ES2986503T3 (es) 2019-05-03 2024-11-11 Zyus Life Sciences Inc Formulación para el manejo del dolor que comprende tetrahidrocannabinol (THC), cannabicromeno (CBC) y cannabidiol (CBD) en una proporción determinada
US12178797B2 (en) 2019-05-03 2024-12-31 Zyus Life Sciences Inc. Formulation for pain management
US12220396B2 (en) 2019-05-03 2025-02-11 Zyus Life Sciences Inc. Formulation for pain management
CA3140916A1 (en) * 2019-05-22 2020-11-26 Canopy Growth Corporation Cannabinoid-comprising compositions for management of pain
PE20230837A1 (es) * 2020-06-12 2023-05-19 Zelira Therapeutics Operations Pty Ltd Composicion y metodo para el tratamiento del dolor cronico
CA3091622A1 (en) 2020-08-28 2022-02-28 Teresa Ann Hanlon Pain relieving formulations containing cannabis and methods of making same
KR102269823B1 (ko) * 2021-01-18 2021-06-28 주식회사 네이처센스 대마 추출물을 포함하는 대사성 질환의 예방 및 치료용 조성물
WO2023278708A1 (en) * 2021-07-01 2023-01-05 Ananda Scientific, Inc. Methods for treatment of pain with cannabinoids
WO2023126934A1 (en) * 2021-12-29 2023-07-06 Canonic Ltd. Cannabis compositions for treating pain and inflammation related disorders
US20250295722A1 (en) 2022-01-28 2025-09-25 Vertanical GmbH Method for the production of a plant extract
KR20240147728A (ko) 2022-01-31 2024-10-08 베르타니컬 게엠베하 델타-9-테트라하이드로칸나비놀 및 테르펜을 포함하는 조성물
WO2024044145A1 (en) * 2022-08-23 2024-02-29 Tribu Hemp Llc Cannabinoid and terpene composition to be applied on an absorbent material.
WO2025027091A1 (en) 2023-08-01 2025-02-06 Vertanical GmbH Composition for use in treatment and/or prevention of chronic musculoskeletal pain including chronic low back pain, chronic non-specific low back pain, osteoarthritis or other chronic musculoskeletal pain conditions comprising delta-9-tetrahydrocannabinol and terpenes

Family Cites Families (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6949582B1 (en) * 1999-05-27 2005-09-27 Wallace Walter H Method of relieving analgesia and reducing inflamation using a cannabinoid delivery topical liniment
CA2895805A1 (en) * 2012-12-18 2014-06-26 Kotzker Consulting Llc Use of cannabinoids and terpenes for treatment of organophosphate and carbamate toxicity
CA2961410C (en) * 2014-09-16 2023-07-11 India Globalization Capital, Inc. Cannabinoid composition and method for treating pain
CN107205960A (zh) * 2014-10-21 2017-09-26 联合大麻公司 大麻提取物及其制备和使用方法
WO2017054071A1 (en) * 2015-01-21 2017-04-06 Willinsky Michael Composition and methods to improve stability, dosing, pharmacodynamics and product shelf life of endocannabinoids, phytocannabinoids and synthetic cannabinoids delivered by nasal inhaler
CA2952335A1 (en) * 2015-12-19 2017-06-19 Delta 9 Gardening B.V. Therapeutic delivery formulations and systems comprising cannabinoids and terpenes
PL3429580T3 (pl) * 2016-03-16 2025-09-22 Buzzelet Development And Technologies Ltd Kompozycja kannabinoidowa wzbogacona terpenami
EP3630145A4 (en) * 2017-05-31 2021-04-07 Phytecs, Inc. PHARMACEUTICAL COMPOSITIONS OF CANNABIDIOL AND BETA-CARYOPHYLLENE AND METHOD FOR USING THEM
US11857530B2 (en) * 2017-10-30 2024-01-02 Endocanna Health, Inc. Cannabinoid formulations

Also Published As

Publication number Publication date
WO2020006599A1 (en) 2020-01-09
EP3817733A4 (en) 2022-05-04
PE20211650A1 (es) 2021-08-24
KR20210071939A (ko) 2021-06-16
AU2019297198A1 (en) 2021-01-28
BR112020027080A2 (pt) 2021-03-30
CO2021001061A2 (es) 2021-06-30
SG11202013239RA (en) 2021-01-28
MX2021000020A (es) 2021-05-27
CA3104742A1 (en) 2020-01-09
IL279748A (en) 2021-03-01
AU2019297198B2 (en) 2022-12-08
US20220218650A1 (en) 2022-07-14
EP3817733A1 (en) 2021-05-12
AU2018100924A4 (en) 2018-08-09

Similar Documents

Publication Publication Date Title
CL2020003368A1 (es) Composicion y metodo para tratar el dolor
CL2020000632A1 (es) Composición y método para el tratamiento del autismo.
MX2018011348A (es) Composiciones de extractos naturales y uso de los mismos para prevenir o tratar enfermedades.
CL2020003373A1 (es) Composición y método de ahorro de opiáceos
CO2017004974A2 (es) Extractos de cannabis y métodos de preparación.
MX2017014195A (es) Hidrogenacion de aceite de cannabis.
MX2019015315A (es) Composiciones y tratamientos para el trastorno del sueño.
PE20200726A1 (es) Composicion de cannabis
PE20230607A1 (es) Composicion de cannabis
MX2021008702A (es) Uso de cannabinoides en el tratamiento de las comorbilidades asociadas a la epilepsia.
PE20200676A1 (es) Composicion de cannabis
MX2017015083A (es) Composiciones cosmeticas que comprenden e/z-bencilideno-5,6-dimeto xi-3,3-dimetilindan-1-ona.
PE20200338A1 (es) Composiciones cannabinoides novedosas y metodos para tratar la epilepsia infantil
CL2022003507A1 (es) Composición y método para tratar el dolor crónico
BR112016017612A2 (pt) Uso de um extrato de uma planta do gênero mentha da família lamiaceae
CL2020003374A1 (es) Composicion y metodo de cannabinoides para tratar el tept y/o la ansiedad
CL2020002646A1 (es) Composición para modular genes responsables de las funciones generales de la piel, que comprende al menos un extracto vegetal seleccionado de casearia sylvestris y schinus terebinthfolius y ácido hialurónico (divisional de la solicitud 03354-2018)
NI201900004A (es) Composición vaginal comprendiendo una combinación de estrógeno y vitamina d.
CO2021012893A2 (es) Polímero superabsorbente y método para aumentar el contenido de azúcar en plantas
EA201991659A1 (ru) Композиция от кашля
MX2021008602A (es) Composicion para el tratamiento y/o prevencion de sintomas del tracto urinario inferior.
BR112018001693A2 (pt) composição farmacêutica para prevenção de queda de cabelo ou promoção de crescimento de cabelo, método para prevenir a queda de cabelo e método para promover o crescimento do cabelo
CL2021001076A1 (es) Composición farmacéutica que comprende una combinación de 1,3-2,5% de tetrahidrocannabinol (thc) y 0,6-1,4% de cannabidiol (cbd); su proceso de elaboración; y su uso para el tratamiento del dolor crónico refractario.
AR116986A1 (es) Composición cosmética, método para la producción de aceite y/o manteca de astrocaryum vulgare, uso de la composición cosmética y método para la producción y/o protección contra la degradación del ácido hialurónico en la piel
AR111810A1 (es) Composición cosmética de textura oleosa, uso y método para prevención y/o tratamiento de las señales de envejecimiento externo y del estrés cutáneo